Private Equity

As robotaxis and self-driving trucks go commercial, a new group from Seeing Machines aims to solve the critical human trust and safety challenge.

Tire giant Michelin buys advanced materials firm Tex-Tech to fuel its diversification, as a new defense-focused composite entity, FMI, is spun off.

Fresh off a major drug approval, Insmed's upcoming J.P. Morgan talk is under scrutiny as investors eye pipeline updates and acquisition potential.

The organic retailer's third Wyoming store will create jobs with competitive pay and shake up the local grocery market when it opens this spring.

Nouveau Monde Graphite issues stock to pay interest to its major investor, Investissement Québec, highlighting a strategy to conserve cash for key projects.

Ironwood Pharma forecasts a massive profit jump by lowering its top drug's price, a bold move as it advances its rare disease pipeline for future growth.

With patent cliffs looming and big bets on M&A, all eyes are on BMS to prove its growth strategy and high-stakes pipeline can deliver in 2026.

RPM International's 52nd straight year of dividend hikes cements its 'Dividend King' status. We look at the strategy behind this rare achievement.

Following the sale of its legacy business, the newly-rebranded Accendra Health launches on the NYSE with a laser focus on the booming home healthcare market.

As INCERGO finalizes its Visual Semiconductor merger, it's betting on GF3D™ tech to revive 3D displays. Can it succeed where 3D TVs failed?

Neovii Pharmaceuticals names Frédéric Prince its next CEO, bringing deep oncology and gene therapy experience from Roche to steer its next growth phase.

Ecovyst completes a major divestiture to slash debt and focus on its core, while Technip Energies acquires key assets to boost its energy transition goals.

Distressed debt giant Silver Point Capital acquires a controlling interest in claims against bankrupt auto parts maker First Brands, a strategic move.

The MICE giant's massive government contract to manage a 185,000-pilgrim yatra signals a strategic shift and a new model for public-private partnerships.

The revered former U.S. Senator announced his withdrawal from public life following a dementia diagnosis, ending a storied career and sparking reflection.

Vivakor blames a government shutdown for its dividend delay, but shareholders are left grappling with an unusual asset and a complex CEO-related deal.

ECN Capital urges shareholders to approve a C$1.9 billion takeover by Warburg Pincus, offering a 13% premium and a shift to private ownership.

As Aircastle prepares its Q3 2025 results, all eyes are on the leasing giant for insights into the supercharged global aviation finance sector.

Interim CFO Donna Granato's departure marks a pivotal moment for Ayr Wellness as it completes a massive debt restructuring and transitions to a new entity.

Euromax Resources raised C$1.6M, but with 84% for overhead and only 9% for its stalled gold project, is this a step forward or just staying afloat?